Abstract
Nanoscale drug delivery applications in cancer therapeutics, termed as nanoncology, are being utilized to resolve recurring problems in conventional drug delivery. Nanoparticles have properties unlike their bulk counterparts and the ongoing development of these characteristics continues to increase the repertoire of bio-functionality in regards to interactions of oncotic cellular and molecular systems. Nanoparticles can be constructed in a manner that is tunable and targeted, which gives standard chemotherapy a new approach in terms of drug administration and lowering off-target toxicities. This work concisely discusses pivotal factors in nanoparticle characteristics for cancer therapy providing an up-to-date therapeutics platforms review.
| Original language | English |
|---|---|
| Pages (from-to) | 1-13 |
| Number of pages | 13 |
| Journal | Journal of Bionanoscience |
| Volume | 4 |
| Issue number | 1-2 |
| DOIs | |
| State | Published - Jun 2010 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer
- Chemotherapy
- Drug Delivery
- Nanobiotechnology
- Nanoncology
- Nanoparticle
- Oncology
- Polymers
- Therapy
- Tumor
Fingerprint
Dive into the research topics of 'Nanoncology: A state-of-art update'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver